MEDRx

About:

MEDRx is a pharmaceutical drug development company that is engaged in the research and development of new medicines for patient.

Website: http://www.medrx.co.jp/

Top Investors: Whiz Partners

Description:

MedRx is a pharmaceutical company that develops pharmaceutical drugs based on the transdermal absorption system in Japan. It develops medicines based on Ionic Liquid Transdermal System. The company’s products in the pipeline include MRX-4TZT; MRX-5LBT; MRX-10XT; and MRX-5DML. It also offers microneedle patch for delivery of vaccines and/or APIs through the skin. MedRx Co., Ltd. was founded in 2002 and is headquartered in Higashikagawa, Japan.

Total Funding Amount:

652M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kagawa, Yamaguchi, Japan

Founded Date:

2002-01-01

Founders:

Hayford Nkansah Brako

Number of Employees:

11-50

Last Funding Date:

2016-06-14

IPO Status:

Public

Industries:

© 2025 bioDAO.ai